Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS | Zendy

Hadar Oz | Zendy; Dov Gavish | Zendy; Anat Hass | Zendy; Marina Shargorodsky | Zendy

Open Access

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS

Author(s) -

Hadar Oz,

Dov Gavish,

Anat Hass,

Marina Shargorodsky

Publication year - 2015

Publication title -

journal of the renin-angiotensin-aldosterone system

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.457

H-Index - 46

eISSN - 1752-8976

pISSN - 1470-3203

DOI - 10.1177/1470320314566017

Subject(s) - candesartan , medicine , osteoprotegerin , endocrinology , angiotensin ii , aldosterone , bone remodeling , blood pressure , receptor , activator (genetics)

The renin-angiotensin-aldosterone system (RAAS) has recently been considered as a possible link between bone and vascular disease. The present study was designed to determine the effect of the angiotensin II receptor blocker candesartan on circulating osteoprotegerin (OPG) in hypertensive patients with multiple cardiovascular risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research